The Pfizer COVID-19 vaccine will be launched in the UK next week

COVID-19 testing continues around the world with the preparation of the first vaccines.

Jens Schlueter / AFP through Getty Images

For the latest news and information on the coronavirus epidemic, visit the WHO website.

The UK has approved the COVID-19 vaccine and plans to implement the treatment as early as next week. They will be residents of the UK care home, older adults and health workers first inoculated with the pioneering vaccine developed by Pfizer and BioNTech a coronavirus pandemic.

The British government has made sure the vaccine is safe, has undergone rigorous clinical trials and the results have been analyzed by the national medical regulator. About 800,000 doses will be distributed to vulnerable people next week, while the majority of the population will be vaccinated in the new year.

The vaccine among several in the competition of world scientists in the fight against the pandemic. Developed by German biotechnology company BioNTech and US pharmaceutical giant Pfizer the first vaccine to use cutting-edge mRNA genetic material to combat the disease. The treatment is reported to be more than 90% effective.

The vaccine should be stored at -70 degrees Celsius (-94 Fahrenheit), so it is expected to be administered first in hospitals until adequate storage is spread out elsewhere.

The USA investigates Pfizer vaccination and the like a vaccine developed by Moderna. The U.S. Food and Drug Administration is expected to follow the UK in approving one or more treatments soon.

Russia and China have already approved the vaccines, but without large-scale tests.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult your doctor or other qualified health care provider if you have any questions about your health condition or your health goals.